Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -0.93% is 249% below its 5-year average of 0.62%, around the middle of its 5-year range (-8.05%–4.88%).
498.84% below its 12-month average of -0.16%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 1.21%.
NET PROFIT MARGIN
-0.93%
NET PROFIT MARGIN AVG TTM
-0.16%
NET PROFIT MARGIN AVG 3Y
0.72%
NET PROFIT MARGIN AVG 5Y
0.62%
NET PROFIT MARGIN AVG 10Y
1.04%
NET PROFIT MARGIN AVG 15Y
1.09%
NET PROFIT MARGIN AVG 20Y
0.10%
CURRENT VS TTM AVG
-498.84%
CURRENT VS 3Y AVG
-229.32%
CURRENT VS 5Y AVG
-249.34%
CURRENT VS 10Y AVG
-189.49%
CURRENT VS 15Y AVG
-185.61%
CURRENT VS 20Y AVG
-1038.66%
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-165.71%
vs the sector median at left
Market Cap
$5.52B
Net Profit Margin
-10.21%
TTM Avg
-9.94%
3Y Avg
-7.18%
5Y Avg
-7.18%
Market Cap
$5.61B
Net Profit Margin
-3602.68%
TTM Avg
-5857.26%
3Y Avg
-13524.50%
5Y Avg
-10844.39%
Market Cap
$5.32B
Net Profit Margin
-3.80%
TTM Avg
-2.80%
3Y Avg
-38.10%
5Y Avg
-60.79%
Market Cap
$5.78B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.79B
Net Profit Margin
-89.09%
TTM Avg
-187.61%
3Y Avg
-9430.16%
5Y Avg
-6286.77%
Market Cap
$5.21B
Net Profit Margin
-3368.72%
TTM Avg
-8808.10%
3Y Avg
-41695.11%
5Y Avg
-35876.65%
Market Cap
$5.21B
Net Profit Margin
-7.35%
TTM Avg
-71.56%
3Y Avg
-118.55%
5Y Avg
-116.04%
Market Cap
$5.20B
Net Profit Margin
13.44%
TTM Avg
5.37%
3Y Avg
-1.91%
5Y Avg
0.03%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RadNet, Inc. (RDNT) | $5.53B | -0.93% | -0.16% | 0.72% | 0.62% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | -10.21% | -9.94% | -7.18% | -7.18% |
| CG Oncology Inc. (CGON)vs › | $5.61B | -3602.68% | -5857.26% | -13524.50% | -10844.39% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | -3.80% | -2.80% | -38.10% | -60.79% |
| Kodiak Sciences Inc. (KOD)vs › | $5.78B | 0.00% | 0.00% | 0.00% | 0.00% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | -89.09% | -187.61% | -9430.16% | -6286.77% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | -3368.72% | -8808.10% | -41695.11% | -35876.65% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | -7.35% | -71.56% | -118.55% | -116.04% |
| Sotera Health Company (SHC)vs › | $5.20B | 13.44% | 5.37% | -1.91% | 0.03% |
| Doximity, Inc. (DOCS)vs › | $5.20B | 25.48% | 34.77% | 31.87% | 32.80% |
Operating Margin
4.0%
Net Profit Margin
-0.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 1.21% |
| 2026-03-31 | -5.81% |
| 2025-12-31 | -0.11% |
| 2025-09-30 | 1.04% |
| 2025-06-30 | 2.90% |
| 2025-03-31 | -8.05% |
| 2024-12-31 | 1.12% |
| 2024-09-30 | 0.70% |
| 2024-06-30 | -0.65% |
| 2024-03-31 | -0.64% |
| 2023-12-31 | -0.44% |
| 2023-09-30 | 4.36% |
| 2023-06-30 | 2.07% |
| 2023-03-31 | -5.38% |
| 2022-12-31 | -0.24% |
| 2022-09-30 | 0.19% |
| 2022-06-30 | 2.23% |
| 2022-03-31 | 0.88% |
| 2021-12-31 | -1.15% |
| 2021-09-30 | 4.88% |
| 2021-06-30 | 0.86% |
| 2021-03-31 | 3.00% |
| 2020-12-31 | 1.93% |
| 2020-09-30 | 2.11% |
| 2020-06-30 | -5.56% |
| 2020-03-31 | -5.81% |
| 2019-12-31 | 3.46% |
| 2019-09-30 | 1.09% |
| 2019-06-30 | 1.69% |
| 2019-03-31 | -1.37% |
| 2018-12-31 | 11.33% |
| 2018-09-30 | 2.08% |
| 2018-06-30 | 2.21% |
| 2018-03-31 | -3.17% |
| 2017-12-31 | -3.09% |
| 2017-09-30 | 1.42% |
| 2017-06-30 | 2.31% |
| 2017-03-31 | -0.53% |
| 2016-12-31 | 1.64% |
| 2016-09-30 | 0.73% |
| 2016-06-30 | 1.66% |
| 2016-03-31 | -0.80% |
| 2015-12-31 | 0.41% |
| 2015-09-30 | 3.83% |
| 2015-06-30 | 1.66% |
| 2015-03-31 | -2.51% |
| 2014-12-31 | 2.27% |
| 2014-09-30 | 2.42% |
| 2014-06-30 | 2.87% |
| 2014-03-31 | -7.36% |
| 2013-12-31 | 0.70% |
| 2013-09-30 | -0.27% |
| 2013-06-30 | 1.52% |
| 2013-03-31 | -0.78% |
| 2012-12-31 | 35.54% |
| 2012-09-30 | 3.15% |
| 2012-06-30 | 1.78% |
| 2012-03-31 | -0.07% |
| 2011-12-31 | 2.72% |
| 2011-09-30 | 0.03% |
| 2011-06-30 | 2.26% |
| 2011-03-31 | -0.60% |
| 2010-12-31 | 2.27% |
| 2010-09-30 | -0.20% |
| 2010-06-30 | -8.46% |
| 2010-03-31 | -3.31% |
| 2009-12-31 | 0.48% |
| 2009-09-30 | -1.29% |
| 2009-06-30 | -0.26% |
| 2009-03-31 | -0.66% |
| 2008-12-31 | -4.17% |
| 2008-09-30 | 0.10% |
| 2008-06-30 | -1.69% |
| 2008-03-31 | -4.77% |
| 2007-12-31 | -12.46% |
| 2007-09-30 | -1.77% |
| 2007-06-30 | 1.24% |
| 2007-03-31 | -4.14% |
| 2006-10-31 | -5.46% |
| 2006-07-31 | -3.46% |
| 2006-04-30 | -6.82% |
| 2006-01-31 | -1.24% |
| 2005-10-31 | -0.76% |
| 2005-07-31 | -0.10% |
| 2005-04-30 | -1.69% |
| 2005-01-31 | -6.44% |
| 2004-10-31 | -20.48% |
| 2004-07-31 | -13.32% |
| 2004-04-30 | -5.29% |
| 2004-01-31 | -3.83% |
| 2003-10-31 | -0.50% |
| 2003-07-31 | -2.23% |
| 2003-04-30 | 1.95% |
| 2003-01-31 | -5.58% |
| 2002-10-31 | -5.81% |
| 2002-07-31 | -14.40% |
